Literature DB >> 19121341

Binding of S100 proteins to RAGE: an update.

Estelle Leclerc1, Günter Fritz, Stefan W Vetter, Claus W Heizmann.   

Abstract

The Receptor for Advanced Glycation Endproducts (RAGE) is a multi-ligand receptor of the immunoglobulin family. RAGE interacts with structurally different ligands probably through the oligomerization of the receptor on the cell surface. However, the exact mechanism is unknown. Among RAGE ligands are members of the S100 protein family. S100 proteins are small calcium binding proteins with high structural homology. Several members of the family have been shown to interact with RAGE in vitro or in cell-based assays. Interestingly, many RAGE ligands appear to interact with distinct domains of the extracellular portion of RAGE and to trigger various cellular effects. In this review, we summarize the modes of S100 protein-RAGE interaction with regard to their cellular functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19121341     DOI: 10.1016/j.bbamcr.2008.11.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  185 in total

1.  S100P is a novel interaction partner and regulator of IQGAP1.

Authors:  Annika Heil; Ali Reza Nazmi; Max Koltzscher; Michaela Poeter; Judith Austermann; Nicole Assard; Jacques Baudier; Kozo Kaibuchi; Volker Gerke
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

2.  The surprising composition of the salivary proteome of preterm human newborn.

Authors:  Massimo Castagnola; Rosanna Inzitari; Chiara Fanali; Federica Iavarone; Alberto Vitali; Claudia Desiderio; Giovanni Vento; Chiara Tirone; Costantino Romagnoli; Tiziana Cabras; Barbara Manconi; Maria Teresa Sanna; Roberto Boi; Elisabetta Pisano; Alessandra Olianas; Mariagiuseppina Pellegrini; Sonia Nemolato; Claus Wilhelm Heizmann; Gavino Faa; Irene Messana
Journal:  Mol Cell Proteomics       Date:  2010-10-13       Impact factor: 5.911

Review 3.  The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome.

Authors:  Weidun Alan Guo; Paul R Knight; Krishnan Raghavendran
Journal:  Intensive Care Med       Date:  2012-07-10       Impact factor: 17.440

4.  Activated cholangiocytes release macrophage-polarizing extracellular vesicles bearing the DAMP S100A11.

Authors:  Tomohiro Katsumi; Maria Eugenia Guicciardi; Adiba Azad; Steven F Bronk; Anuradha Krishnan; Gregory J Gores
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-31       Impact factor: 4.249

5.  Receptor for Advanced Glycation End-Products (RAGE) Blockade Do Damage to Neuronal Survival via Disrupting Wnt/β-Catenin Signaling in Spinal Cord Injury.

Authors:  Hongyu Wang; Ziming Zhao; Chang Liu; Zhanpeng Guo; Yajiang Yuan; Haoshen Zhao; Zipeng Zhou; Xifan Mei
Journal:  Neurochem Res       Date:  2018-05-22       Impact factor: 3.996

Review 6.  Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.

Authors:  Geetha Srikrishna; Hudson H Freeze
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

7.  Relating form and function of EF-hand calcium binding proteins.

Authors:  Walter J Chazin
Journal:  Acc Chem Res       Date:  2011-02-11       Impact factor: 22.384

8.  S100A8/A9 activate key genes and pathways in colon tumor progression.

Authors:  Mie Ichikawa; Roy Williams; Ling Wang; Thomas Vogl; Geetha Srikrishna
Journal:  Mol Cancer Res       Date:  2011-01-12       Impact factor: 5.852

9.  Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling.

Authors:  Jing Xue; Michaele Manigrasso; Matteo Scalabrin; Vivek Rai; Sergey Reverdatto; David S Burz; Daniele Fabris; Ann Marie Schmidt; Alexander Shekhtman
Journal:  Structure       Date:  2016-08-11       Impact factor: 5.006

10.  S100B protein in tissue development, repair and regeneration.

Authors:  Guglielmo Sorci; Francesca Riuzzi; Cataldo Arcuri; Claudia Tubaro; Roberta Bianchi; Ileana Giambanco; Rosario Donato
Journal:  World J Biol Chem       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.